Cover Image
市場調查報告書

SOM Innovation Biotech SL:產品平台分析

SOM Innovation Biotech SL - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 351250
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
SOM Innovation Biotech SL:產品平台分析 SOM Innovation Biotech SL - Product Pipeline Review - 2015
出版日期: 2015年12月30日 內容資訊: 英文 32 Pages
簡介

SOM Innovation Biotech SL 為致力於已知藥物的新的適應症的生物製藥公司,提供專利取得,藥物研發、 臨床前評估及其概念驗證(POC),及且已知藥物的授權服務。該公司的產品活用於代謝障礙和神經學,泌尿系統學及腫瘤學相關罕見疾病的領域。

本報告提供SOM Innovation Biotech SL 提供著的治療藥開發平台的現狀及各開發階段比較分析,各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估,最新的企業新聞和發表,後期階段及中止的計劃相關資訊等。

SOM Innovation Biotech SL的基本資料

  • SOM Innovation Biotech SL概要
  • 主要資訊
  • 企業資料

SOM Innovation Biotech SL:R&D概要

  • 主要的治療範圍

SOM Innovation Biotech SL:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

SOM Innovation Biotech SL:開發中產品概況

  • 臨床實驗階段有的開發中產品
    • 第Ⅱ階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段有的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

SOM Innovation Biotech SL:藥物簡介

  • Torcaphone
  • SOM-3355
  • SOM-2391
  • SOM-2393
  • resutauruchinibu
  • SOM-2485
  • SOM-7400

SOM Innovation Biotech SL:開發平台分析

  • 各標的
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

SOM Innovation Biotech SL:最近的開發平台趨勢

SOM Innovation Biotech SL:暫停中的計劃

SOM Innovation Biotech SL:暫停中的計劃

SOM Innovation Biotech SL:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC07935CDB

Summary

Global Markets Direct's, 'SOM Innovation Biotech SL - Product Pipeline Review - 2015', provides an overview of the SOM Innovation Biotech SL's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of SOM Innovation Biotech SL's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of SOM Innovation Biotech SL including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of SOM Innovation Biotech SL's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the SOM Innovation Biotech SL's pipeline products

Reasons to buy

  • Evaluate SOM Innovation Biotech SL's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of SOM Innovation Biotech SL in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the SOM Innovation Biotech SL's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of SOM Innovation Biotech SL and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of SOM Innovation Biotech SL
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of SOM Innovation Biotech SL and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • SOM Innovation Biotech SL Snapshot
    • SOM Innovation Biotech SL Overview
    • Key Information
    • Key Facts
  • SOM Innovation Biotech SL - Research and Development Overview
    • Key Therapeutic Areas
  • SOM Innovation Biotech SL - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • SOM Innovation Biotech SL - Pipeline Products Glance
    • SOM Innovation Biotech SL - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • SOM Innovation Biotech SL - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • SOM Innovation Biotech SL - Drug Profiles
    • tolcapone
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SOM-3355
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SOM-2391
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SOM-2393
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • lestaurtinib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SOM-2485
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SOM-7400
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • SOM Innovation Biotech SL - Pipeline Analysis
    • SOM Innovation Biotech SL - Pipeline Products by Target
    • SOM Innovation Biotech SL - Pipeline Products by Route of Administration
    • SOM Innovation Biotech SL - Pipeline Products by Molecule Type
    • SOM Innovation Biotech SL - Pipeline Products by Mechanism of Action
  • SOM Innovation Biotech SL - Recent Pipeline Updates
  • SOM Innovation Biotech SL - Dormant Projects
  • SOM Innovation Biotech SL - Dormant Projects
  • SOM Innovation Biotech SL - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • SOM Innovation Biotech SL, Key Information
  • SOM Innovation Biotech SL, Key Facts
  • SOM Innovation Biotech SL - Pipeline by Indication, 2015
  • SOM Innovation Biotech SL - Pipeline by Stage of Development, 2015
  • SOM Innovation Biotech SL - Monotherapy Products in Pipeline, 2015
  • SOM Innovation Biotech SL - Out-Licensed Products in Pipeline, 2015
  • SOM Innovation Biotech SL - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • SOM Innovation Biotech SL - Phase II, 2015
  • SOM Innovation Biotech SL - Phase I, 2015
  • SOM Innovation Biotech SL - Preclinical, 2015
  • SOM Innovation Biotech SL - Discovery, 2015
  • SOM Innovation Biotech SL - Pipeline by Target, 2015
  • SOM Innovation Biotech SL - Pipeline by Route of Administration, 2015
  • SOM Innovation Biotech SL - Pipeline by Molecule Type, 2015
  • SOM Innovation Biotech SL - Pipeline Products by Mechanism of Action, 2015
  • SOM Innovation Biotech SL - Recent Pipeline Updates, 2015
  • SOM Innovation Biotech SL - Dormant Developmental Projects,2015

List of Figures

  • SOM Innovation Biotech SL - Pipeline by Top 10 Indication, 2015
  • SOM Innovation Biotech SL - Pipeline by Stage of Development, 2015
  • SOM Innovation Biotech SL - Monotherapy Products in Pipeline, 2015
  • SOM Innovation Biotech SL - Pipeline by Top 10 Target, 2015
  • SOM Innovation Biotech SL - Pipeline by Top 10 Molecule Type, 2015
  • SOM Innovation Biotech SL - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top